Korean J Thorac Cardiovasc Surg.  2000 Mar;33(3):268-272.

Botulinum A toxin for the treatment of focal hyperhidrosis: 5 cases

Affiliations
  • 1Department of Thoracic and Cardiovascular Surgery, College of Medicine, Korea University, Seoul.

Abstract

Thoracic sympathicotomy has been used safely and successfully to treat essential hyperhidrosis. However, it has been difficult to treat compansatory hyperhidrosis after thoracic sympathicotomy and focal hyperhidrosis. The sweat glands were innervated by post-ganglionic sympathetic fibers with acetylcholic serving as the transmitter. Botulinum A toxin has been reported to block neuro-transmission at the cholinergic autonomic nerve terminals. Prospecting its effect for the sweat gland, we treated 5 patients with focal hyperhidrosis with botulinum A toxin. Three patients received bilateral thoracic sympathectomy (1 case) and sympathicotomy(2 case) via VAT. The hyperhidrosis area was marked with betadine and was subdivided into squares of 2x2 cm(4cm(2)) each. Botulinum A toxin was injected intracutaneously in a dosage of 2.5U/0.1ml(100U/4ml) /4cm(2). A total dose of 100U of Botulinum A toxin was injected into the affected sites. Subjective assessment of sweat production by the patients using a visual analogue scale showed a 20~70% improvement. During the follow-up period, no toxic effects were observed.

Keyword

Hyperhidrosis; Toxin

MeSH Terms

Adrenergic Fibers
Autonomic Pathways
Botulinum Toxins, Type A*
Follow-Up Studies
Humans
Hyperhidrosis*
Povidone-Iodine
Sweat
Sweat Glands
Sympathectomy
Botulinum Toxins, Type A
Povidone-Iodine
Full Text Links
  • KJTCS
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr